Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Arbli. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Losartan is combined with Abacavir.
Level 2 evidence
Abatacept
The metabolism of Losartan can be increased when combined with Abatacept.
Level 1 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Losartan is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Losartan is combined with Abiraterone.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Losartan is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Losartan.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Losartan.
Level 2 evidence
Acebutolol
Losartan may increase the arrhythmogenic activities of Acebutolol.
Level 1 evidence
Aceclofenac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Aceclofenac.
Level 1 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Losartan.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Losartan is combined with Acetazolamide.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Losartan.
Level 2 evidence
Enter your NPI to unlock 3 major interactions for Arbli
Arbli (Losartan Potassium) has 1083 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Arbli (Losartan Potassium) has 48 major, 880 moderate, and 155 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Arbli. Always confirm against the full prescribing information.